Benitec Biopharma reported earnings of -$ 0.26 per BNTC share on Nov 13, 2026, falling short of analysts' expectations by
| Report Date | Nov 13, 2026 |
|---|---|
| Forecasted EPS | -$ 0.28 |
| Earnings Per Share (Surprise) | -$ 0.26 (+$ 0.015) |
| Last Year's EPS | -$ 0.29 |
| EPS YoY Change |
Out of the last 58 earnings reporting periods, Benitec Biopharma beat analysts’ expectations 12 times and fell short of expectations 13 time(s). Benitec Biopharma reported earnings per share of -$ 0.26 in the last report surpassing an estimated EPS of -$ 0.28 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 0.28 | -$ 0.26 | -$ 0.22 | |
| Sep 14, 2026 | -$ 0.26 | -$ 0.26 | -$ 0.42 | |
| May 14, 2026 | -$ 0.27 | -$ 0.24 | -$ 0.24 | |
| Feb 12, 2026 | -$ 0.23 | -$ 0.26 | -$ 0.36 | |
| Nov 14, 2025 | -$ 0.35 | -$ 0.22 | -$ 0.48 | |
| Sep 22, 2025 | -$ 0.28 | -$ 0.42 | -$ 1.32 | |
| May 14, 2025 | -$ 0.36 | -$ 0.24 | -$ 1.64 | |
| Feb 14, 2025 | -$ 1.00 | -$ 0.36 | -$ 2.64 | |
| Nov 14, 2024 | -$ 0.55 | -$ 0.48 | -$ 2.76 | |
| Sep 26, 2024 | -$ 0.49 | -$ 1.32 | -$ 2.83 | |
| May 13, 2024 | -$ 0.78 | -$ 1.64 | -$ 2.72 | |
| Feb 13, 2024 | -$ 0.39 | -$ 2.64 | -$ 3.40 | |
| Nov 13, 2023 | -$ 0.51 | -$ 2.76 | -$ 0.47 | |
| Sep 21, 2023 | -$ 3.23 | -$ 2.83 | -$ 10.54 | |
| May 15, 2023 | -$ 0.20 | -$ 2.72 | -$ 6.80 | |
| Feb 13, 2023 | -$ 1.87 | -$ 3.40 | -$ 10.03 | |
| Nov 10, 2022 | -$ 2.04 | -$ 0.47 | -$ 10.54 | |
| Sep 2, 2022 | -$ 4.76 | -$ 10.54 | -$ 5.10 | |
| May 16, 2022 | -$ 7.48 | -$ 6.80 | -$ 0.82 | |
| Feb 14, 2022 | - | -$ 10.03 | -$ 0.76 |
Benitec Biopharma’s stock was trading at $ 9.09 on Nov 12, 2026 a day before the last earnings report was released.
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 0.26 | $ 9.09 | ||
| Sep 14, 2026 | -$ 0.26 | $ 12.19 | $ 11.05 | |
| May 14, 2026 | -$ 0.24 | $ 11.65 | $ 11.49 | |
| Feb 12, 2026 | -$ 0.26 | $ 11.65 | $ 10.38 | |
| Nov 14, 2025 | -$ 0.22 | $ 13.15 | $ 13.53 | |
| Sep 22, 2025 | -$ 0.42 | $ 13.45 | $ 13.22 | |
| May 14, 2025 | -$ 0.24 | $ 13.18 | $ 13.50 | |
| Feb 14, 2025 | -$ 0.36 | $ 9.70 | $ 11.26 | |
| Nov 14, 2024 | -$ 0.48 | $ 10.44 | $ 10.68 | |
| Sep 26, 2024 | -$ 1.32 | $ 8.80 | $ 9.23 | |
| May 13, 2024 | -$ 1.64 | $ 9.25 | $ 8.43 | |
| Feb 13, 2024 | -$ 2.64 | $ 2.85 | $ 2.80 | |
| Nov 13, 2023 | -$ 2.76 | $ 3.42 | $ 3.68 | |
| Sep 21, 2023 | -$ 2.83 | $ 2.94 | $ 3.05 | |
| May 15, 2023 | -$ 2.72 | $ 3.60 | $ 3.71 | |
| Feb 13, 2023 | -$ 3.40 | $ 4.59 | $ 4.08 | |
| Nov 10, 2022 | -$ 0.47 | $ 2.53 | $ 2.77 | |
| Sep 2, 2022 | -$ 10.54 | $ 12.07 | $ 10.56 | |
| May 16, 2022 | -$ 6.80 | $ 20.13 | $ 17.85 | |
| Feb 14, 2022 | -$ 10.03 | $ 49.47 | $ 46.07 |
Benitec Biopharma released its most recent earnings reports in November 2026, September 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Benitec Biopharma beat analysts’ expectations during the last earnings period by
